ArticleScientific reports2021

Molecular mechanisms of the anti-cancer drug, LY2874455, in overcoming the FGFR4 mutation-based resistance.

Fariba Dehghanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.